The decision followed an 80-minute consultation with Dr. Brian Chon, the center’s medical director. Tim noted that the physician’s ability to demystify complex treatment options provided the clarity needed to commit to the long-distance regimen. Unlike experiences at larger hospitals where patients often feel handed off to staff, Tim credited Dr. Chon with maintaining personal oversight throughout the entire 28-session course.
Proton therapy targets malignant cells while sparing surrounding healthy tissue, a priority that drove Tim’s choice. Dr. Chon emphasized that this level of personalized care—balancing technical precision with consistent communication—is what draws patients from across the region and abroad. Since opening in 2012, the Somerset facility has treated over 8,000 patients, offering a non-surgical alternative for various cancers that aims to minimize downtime and preserve quality of life.

Comments (0)
No comments yet. Be the first!